Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to $10.8 million.

  • Biofrontera's Shares Outstanding (Diluted Average) rose 8664.27% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 8664.27%. This contributed to the annual value of $5.5 million for FY2024, which is 25674.48% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Shares Outstanding (Diluted Average) is $10.8 million, which was up 8664.27% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Diluted Average) peaked at $17.1 million during Q1 2022, and registered a low of $941175.0 during Q2 2022.
  • For the 5-year period, Biofrontera's Shares Outstanding (Diluted Average) averaged around $5.5 million, with its median value being $5.3 million (2024).
  • In the last 5 years, Biofrontera's Shares Outstanding (Diluted Average) crashed by 9220.84% in 2023 and then soared by 32243.31% in 2024.
  • Quarter analysis of 5 years shows Biofrontera's Shares Outstanding (Diluted Average) stood at $8.0 million in 2021, then plummeted by 86.79% to $1.1 million in 2022, then skyrocketed by 46.29% to $1.5 million in 2023, then surged by 256.74% to $5.5 million in 2024, then skyrocketed by 95.36% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q3 2025, $9.4 million for Q2 2025, and $8.9 million during Q1 2025.